FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 14:25:37 2024-06-14 EDT | ||
| 0.54 EUR | -2.88% |
|
| Current month | -15.89% | ||
| 1 month | -29.78% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 0.54 | -2.88% |
| 24-06-13 | 0.556 | -5.44% |
| 24-06-12 | 0.588 | -1.67% |
| 24-06-11 | 0.598 | -3.08% |
| 24-06-10 | 0.617 | -6.37% |
Real-time BOERSE MUENCHEN
Last update June 14, 2024 at 02:25 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GK5U5A |
| ISIN | DE000GK5U5A0 |
| Date issued | 2022-06-01 |
| Strike | 255.9 $ |
| Maturity | Unlimited |
| Parity | 72.01 : 1 |
| Emission price | 3.03 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.66 € |
|---|---|
| Lowest since issue | 0.258 € |
| Spread | 0.01 € |
| Spread % | 1.79% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
298.6
USD
Average target price
316.4
USD
Spread / Average Target
+5.97%
- Stock Market
- Certificates
- Certificat
